Literature DB >> 2273209

Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome.

R Abs1, A Beckers, F L Van de Vyver, A De Schepper, A Stevenaert, G Hennen.   

Abstract

A 36-year-old woman is reported with a possible variant of the McCune-Albright syndrome. The triad was incomplete because of the absence of skin pigmentation and since the sexual precocity was not evident. The presence of a pituitary mass and the secretory dynamics of growth hormone and prolactin were suggestive of a mammosomatotroph cell adenoma. A toxic multinodular goiter was also associated, but unique was the spontaneous normalization of the thyroid function. Unusual was the silent evolution of the polyostotic fibrous dysplasia, which was only fortuitously discovered during magnetic resonance imaging of the pituitary region. Treatment of the acromegaly with the long-acting somatostatin analogue octreotide resulted in an important inhibition of the GH secretion and in a reduction of the volume of the pituitary adenoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2273209     DOI: 10.1007/BF03349592

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  26 in total

1.  Ovarian function in girls with McCune-Albright syndrome.

Authors:  C M Foster; P Feuillan; V Padmanabhan; O H Pescovitz; I Z Beitins; F Comite; T H Shawker; D L Loriaux; G B Cutler
Journal:  Pediatr Res       Date:  1986-09       Impact factor: 3.756

2.  McCune-Albright syndrome with acromegaly.

Authors:  K K Pun; G Chan; A Kung; K Lam; F L Chan; C Wang
Journal:  Horm Metab Res       Date:  1989-09       Impact factor: 2.936

3.  Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (Mc Cune--Albright syndrome).

Authors:  C Polychronakos; G Tsoukas; J R Ducharme; J Letarte; R Collu
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

4.  Polyostotic fibrous dysplasia with acromegaly.

Authors:  R I Harris
Journal:  Am J Med       Date:  1985-03       Impact factor: 4.965

5.  Hyperprolactinaemia in a patient with the McCune-Albright Syndrome.

Authors:  D Carr; I K Mathie; A R Manners; C Colman
Journal:  Br J Obstet Gynaecol       Date:  1979-04

6.  The McCune-Albright syndrome.

Authors:  N Mauras; R M Blizzard
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1986

7.  Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome.

Authors:  L Cuttler; J A Jackson; M Saeed uz-Zafar; L L Levitsky; R C Mellinger; L A Frohman
Journal:  J Clin Endocrinol Metab       Date:  1989-06       Impact factor: 5.958

8.  The Albright syndrome associated with acromegaly: report of a case and review of the literature.

Authors:  A Lipson; T H Hsu
Journal:  Johns Hopkins Med J       Date:  1981-07

9.  Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction.

Authors:  K F Chung; J Alaghband-Zadeh; A Guz
Journal:  Am J Dis Child       Date:  1983-02

10.  Gigantism associated with McCune-Albright's syndrome.

Authors:  H Nakagawa; A Nagasaka; T Sugiura; K Nakagawa; Y Yabe; N Nihei; M Hirooka; M Itoh; A Nakai; T Ohyama
Journal:  Horm Metab Res       Date:  1985-10       Impact factor: 2.936

View more
  7 in total

1.  Polyostotic fibrous dysplasia with gigantism and huge pelvic tumor: a rare case of McCune-Albright syndrome.

Authors:  Kenshi Sakayama; Yoshifumi Sugawara; Teruki Kidani; Taketsugu Fujibuchi; Katsumi Kito; Nozomu Tanji; Atsushi Nakamura
Journal:  Int J Clin Oncol       Date:  2010-09-29       Impact factor: 3.402

2.  McCune-Albright syndrome: surgical and therapeutic challenges in GH-secreting pituitary adenomas.

Authors:  Helen Madsen; Manuel Thomas Borges; Janice M Kerr; Kevin O Lillehei; B K Kleinschmidt-Demasters
Journal:  J Neurooncol       Date:  2010-11-21       Impact factor: 4.130

3.  Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.

Authors:  S I Sherman; P W Ladenson
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

Review 4.  A case of pituitary adenoma associated with McCune-Albright syndrome.

Authors:  S Sakaki; S Yokoyama; K Mamitsuka; M Nakayama; M Goto; J Kuratsu
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

Review 5.  Acromegaly and McCune-Albright syndrome.

Authors:  Sylvie Salenave; Alison M Boyce; Michael T Collins; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2014-02-11       Impact factor: 5.958

6.  Treatment protocols for growth hormone-secreting pituitary adenomas combined with craniofacial fibrous dysplasia: A case report of atypical McCune-Albright syndrome.

Authors:  Jia Xu; Xi Li; Chang-Sheng Lv; Ying Chen; Meng Wang; Jian-Feng Liu; Lai Gui
Journal:  Exp Ther Med       Date:  2014-06-19       Impact factor: 2.447

Review 7.  Clinical Characteristics and Management of Patients With McCune-Albright Syndrome With GH Excess and Precocious Puberty: A Case Series and Literature Review.

Authors:  Xiao Zhai; Lian Duan; Yong Yao; Bing Xing; Kan Deng; Linjie Wang; Feng Feng; Zhiyong Liang; Hui You; Hongbo Yang; Lin Lu; Shi Chen; Renzhi Wang; Hui Pan; Huijuan Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-29       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.